26
Nov
2024

Damaira Pharmaceuticals Pvt Ltd

Exhibitor at CPHI & PMEC India 2024 stand RH.N18
About Us

Damaira Pharmaceuticals runs a well-established manufacturing facility which is solely dedicated to the production of FinshedCarbapenem Dry Powder Injections, a class of strong antibiotics used for treating severe bacterial infections.

The facility is based on norms laid out by strict regulatory authorities and all measures taken are at par with international standards to assure high quality of medicines.

  • IN
  • 2023
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Hospital / Health Centre
Pharmaceutical company
Primary activities
Finished Formulation products Distributor/Buyer
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI & PMEC India 2024
  • 26 Nov 2024 - 28 Nov 2024
  • India Expo Centre, Greater Noida, Delhi NCR
  • Visit us at stand RH.N18

Products Featured at CPHI & PMEC India 2024

  • Meropenem 500 mg Powder for Injection

    Product Meropenem 500 mg Powder for Injection

    Meropenem is indicated for all age group including infants above 3 months of age as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: Pneumonias and Nosocomial Pneumonias Urinary Tract Infections Intra-abdominal Infect...
  • Biapenem

    Product Biapenem

    Biapenem is a trusted broad - spectrum antibiotic for healthcare professionals with proven clinical effectiveness.it is well - suited therapy for various infections, including those caused by multidrug - resistant bacteria. it ensures optimal patient care and successful treatment outcomes.
  • Doripenem

    Product Doripenem

    Doripenem is an exceptional antibiotic which is effective against complicated infections which offers broad - spectrum coverage and reliable treatment outcomes.

    Doripenem is an indispensable tool for healthcare providers that combat a wide array of infectious diseases.
  • Ertapenem

    Product Ertapenem

    Ertapenem is versatile antibiotic with the advantage of once - daily dosing and broad - spectrum coverage. it is widely used for various infections, especially for surgical and hospital - acquired infections. it is an essential part of modern healthcare, that ensures the best possible outcomes.
  • Imipenem Cilastatin

    Product Imipenem Cilastatin

    Imipenem Cilastatin is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below

     

    Lower respiratory tract infectionsUrinary tract infections (complicated and uncomplicated)Intra-abdominal infec...
  • Meropenem

    Product Meropenem

    Meropenem is indicated for all age group including infants above 3 months of age as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms:

    Pneumonias and Nosocomial PneumoniasUrinary Tract InfectionsIntra-abdominal...